1. Home
  2. IPWR vs PLRX Comparison

IPWR vs PLRX Comparison

Compare IPWR & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ideal Power Inc.

IPWR

Ideal Power Inc.

HOLD

Current Price

$3.98

Market Cap

65.4M

Sector

Industrials

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.09

Market Cap

68.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPWR
PLRX
Founded
2007
2015
Country
United States
United States
Employees
17
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.4M
68.7M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
IPWR
PLRX
Price
$3.98
$1.09
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$10.75
$2.67
AVG Volume (30 Days)
184.8K
706.8K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.97
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2,603.56
N/A
Revenue Next Year
$1,800.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.62
$1.05
52 Week High
$9.30
$1.95

Technical Indicators

Market Signals
Indicator
IPWR
PLRX
Relative Strength Index (RSI) 33.12 40.45
Support Level $2.80 N/A
Resistance Level $4.44 $1.37
Average True Range (ATR) 0.32 0.05
MACD -0.03 -0.00
Stochastic Oscillator 8.89 19.23

Price Performance

Historical Comparison
IPWR
PLRX

About IPWR Ideal Power Inc.

Ideal Power Inc is engaged in the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: